Ample evidence supports the association of CD24 expression with chemotherapy resistance, such as its association with doxorubicin and paclitaxel resistance in endometrial cancer cells [25], doxorubicin and cisplatin resistance in ovarian cancer cells [26], and gemcitabine resistance in pancreatic cancer cells [27]. This evidence concerns the gene CD24 and ovarian carcinoma.